Glaucoma Therapeutics Market to Register Unwavering Growth During 2020 to 2026
Verfasser: ashwani_kailiya on Wednesday, 19 August 2020The global glaucoma therapeutics market is expected to expand to a US$ 7.6 Bn valuation by 2026. The Fact.MR report says, the coronavirus outbreak has resulted in suspended operations of ophthalmic practices, with treatments often being postponed. Consequently, the demand for glaucoma therapeutics solutions has gone down significantly. In addition, the production of associated drugs has also slumped, as a large section of pharmaceutical resources have been directed towards the covid-19 crisis.
"Innovations in diagnostic tools and an expanding demographic of elderly patients are key factors that aid the growth of the glaucoma therapeutics market. Further, awareness programs in emerging economies will also contribute to growth of the industry post pandemic," says the FACT.MR report.
Request a report sample to gain more market insights at: https://www.factmr.com/connectus/sample?flag=S&rep_id=4775
Glaucoma Therapeutics Market- Key Takeaways
Prostaglandin analog drugs are highly preferred among ophthalmologists owing to reduced side effects in intraocular pressure attributes.
Open angle glaucoma, as the most prevalent indication will account for most glaucoma therapeutics applications.
North America remains a dominant market owing to high number of cases, and investments into ophthalmic infrastructure.